INTRODUCTION
Matrine and sophocarpine are two common alkaloids exist in the roots of Sophora flavescens Ait (SFA), which is commonly used as an important ingredient in traditional Chinese herbal medicines to treat viral hepatitis, cancer, cardiac diseases (such as viral myocarditis) and skin diseases (such as psoriasis and eczema).1 Some herbal medicines must be used with caution because they may be toxic to human beings. There are some reports about those excessive doses of matrine alkaloids can have adverse effects.2-4 Therefore, it is necessary to determine and control the contents in biological samples, such as plasma and urine.
Several methods have been developed for the determination of matrine or sophocarpine including high-performance capillary electrophoresis (HPCE),5 high-performance liquid chromatography (HPLC),6 gas chromatography-mass spectrometry (GCMS) 7 and liquid chromatography-mass spectrometry (LC-MS).8 But most of them utilize plasma protein precipitation to delete the matrix disturbance, which have low accuracy and are difficult to operate. Sample extraction that cleans-up the sample matrix and concentrates trace amounts of the analyte are essential aspects of the analysis of biological sample. Traditional methods, such as liquid-liquid extraction (LLE)9 and solid phase extraction (SPE),10 are tedious, time-consuming and consume large amounts of solvent. Recently, new microextraction techniques such as solid phase microextraction (SPME),11,12 and liquid phase microextraction (LPME)13 have been developed because they are simple, fast and solvent-free or with less consumption of organic solvent. Among these techniques, liquid phase microextraction using a hollow fiber (HF-LPME)14 provides a simple, effective, economic and environmentally benign extraction method. In addition, HF-LPME can also show some selectivity. Large molecules, such protein molecules cannot be extracted into the hollow fiber because the limitation of the pore of the fiber. HF-LPME includes two modes. In two-phase LPME, the analytes are extracted from an aqueous sample matrix into an organic solvent acceptor phase. In three-phase LPME, the unionized analytes are first extracted from the aqueous sample, entering into a thin layer of an organic phase inside the wall pores of the hollow fiber, and are then further extracted into the lumen of the hollow fiber, which holds a small volume of an aqueous-based acceptor phase. HF-LPME methods have been applied widely in many fields, such as pesticides,15,16 tetracycline antibiotics,17 diuretics18 and other analytes.19-21
In this study, a HF-LPME method was used to extract matrine alkaloids from urine samples for the first time. The optimized parameters affecting the HF-LPME extraction efficiency including the pH and ionic strength of the donor solution, the pH of acceptor solution, stirring rate and extraction time were evaluated. The detection limits, linear ranges and precision of the technique as well as the feasibility of applying this method to human urine were studied.
EXPERIMENTAL
Reagents, Materials and Solutions
Matrine (purity, 99.8%) and sophocarpine (purity, 99.8%) were obtained from the National Institute for the Control of Pharmaceuticals and Biological Products of China, Beijing, China, and used without further purification. Acetonitrile (HPLC grade), and diethylamine (99.5%) were obtained from Duksan Pure Chemical Co., LTD (Ansan, Korea). All the other reagents used in the experiment were HPLC or analytical grade. Double distilled water was filtered with a vacuum pump (Division of Millipore, Waters, U.S.A.) and filter (HA-0.45, Division of Millipore, Waters, U.S.A.) before use. All the samples were filtered by using a filter (MFS-25, 0.2 μm TF, WHATMAN, U.S.A.) before injection into the HPLC system.
Stock solutions of matrine and sophocarpine were prepared by dissolving 10 mg of standards in 10 mL methanol. Blank human urine (pH 6.0) from healthy volunteers was stored at -20 ℃ and kept at 4 ℃ before use.
Chromatography
Chromatography was performed with a Waters 600 s multisolvent delivery system, a Waters 616 liquid chromatograph, and a Waters 2487 variable wavelength, dual-channel, UV detector (Waters Associates, Milford, MA, USA). A six-port Rheodyne injector (20-μL sample loop) was also used. Data processing was performed with Millennium 3.2 software resident in an HP Vectra 500PC. Compounds were separated on a 250 mm × 4.6 mm, 5-μm particle, OptimaPak C18 column (RS Tech, Daejeon, Korea). HPLC separation of matrine alkaloids was conducted by using methanol/water/diethylamine (40/60/0.10, v/v/v) as mobile phase at a flow rate of 0.5 mL/min and the detection was carried out at a wavelength of 220 nm.
Distilled water was filtered with a vacuum pump and filter (HA-0.45 μm; Millipore, Waters, USA) before use. All samples were filtered (Whatman, USA; MFS-25, 0.2 μm TF filter) before injection for HPLC analysis.
Extraction Procedure
All the extractions were carried out using a polypropylene hollow fiber (Wuppertal, Germany) with a 0.2 μm pore size, 600 μm internal diameter and 200 μm wall thickness. The hollow fibers were cut into 7.0 cm long pieces. 2 mL of a 1 mol/L NaOH solution was palced into a 4 mL vial. Subsequently, 200 μL of a 0.05 mg/mL matrine and sophocarpine mixture was added. Finally, 1800 μL human urine was added to make a total volume of 4.0 mL. The hollow fiber was dipped in 1-octanol for 5 s to ensure that the pores of the hollow fiber had been impregnated with the extracting solvent. After solvent impregnation, the fiber was ultrasonificated for 10 s in a water bath to remove the excess of the solvent. Subsequently, 20 μL of a 100 mmol/L H3PO4 solution (acceptor solution) was injected into the lumen of the hollow fiber with a micro syringe. The impregnated and filled fiber was then placed in the sample vial as shown in Fig. 1 for immediate extraction. Both open ends of the medical syringe needles were connected to the syringe bodies in order to prevent solvent volatilization during extraction. During the extraction, the sample solution was stirred continuously at room temperature with a magnetic stirrer at 600 rpm for 60 min. After extraction, one end of the fiber was detached from the medical syringe needle and 10 μL of the extraction solvent was analyzed directly by HPLC. Each segment of the hollow fiber was used only for a single extraction in order to delete the memory effect.
Fig. 1.Schematic illustration of HF-LPME.
RESULTS AND DISCUSSION
The extraction recovery (R) and the concentration enrichment factor (E) were calculated using equations (1) and (2):22
In the equations, ns,initial and na,final denote the number of moles of analyte present originally in the donor phase and finally collected in the acceptor phase, respectively. Cs,initial and Ca,final are the initial concentration of the analyte in the donor phase and the final concentration of the analyte in the acceptor phase, respectively. Va is the volume of the acceptor phase, and Vs is the volume of undiluted sample.
The factors influencing HF-LPME extraction efficiency including different organic extraction solvent, the pH and ion strength of the donor solution, the pH of the acceptor solution, stirring rate and extraction time, were optimized to obtain the highest enrichment efficiency and high analytical sensitivity.
Selection of Organic Solvent
During the HF-LPME process, the type of organic extraction solvent immobilized in the porous hollow fiber is an essential consideration for efficient extraction. The organic solvent greatly affects the partition coefficients between the donor sample and the organic solvent, as well as between the organic solvent and acceptor phase. In three-phase HF-LPME, the ideal organic solvent should be easily immobilized on the hollow fiber, and be immiscible with the aqueous phase with low volatility. In this study, four different organic solvents, 1-octanol, toluene, cyclohexane and chloroform were examined. As shown in Table 1, the highest enrichment factor of matrine and sophocarpine was achieved by 1-octanol. Therefore, 1-octanol was selected as the extraction solvent for further optimization.
Table 1.Selection of organic phase
Effect of pH of Donor Phase and Acceptor Phase
The acidity and basicity of the donor phase and acceptor phases can highly influence the extraction efficiency. The pKa of matrine and sophocarpine was 7.7 and 7.2, respectively. Hence, they belong to basic drugs. For basic drugs, the donor phase should be strongly alkalized in order to effectively deionize the analytes and reduce their solubility in the donor phase, while the acceptor phase should be acidified in order to promote dissolution of the basic analytes. Different concentrations of NaOH were added to the sample solution to adjust the pH of donor phase. As a result, the best extraction efficiency was observed at pH 13.7 (0.5 mol/L of NaOH).
100 mmol/L of H3PO4 as the acceptor solution at seven different pH (1.2, 2.0, 3.0, 4.0, 5.5, 6.0 and 7.0) was examined to optimize the acceptor pH. As shown in the Fig. 2, the enrichment factor of the matrine alkaloids decreased with increaseing pH of the acceptor solution. Therefore, a pH of 1.5 was selected as the acceptor solution.
Fig. 2.Chromatograms of blank human urine and human urine spiked with 2.5 μg/mL matrine and sophocarpine extracted by HF-LPME. HF-LPME condition: donor solution: (2 mL human urine containing 5 μg/mL matrine and sophcarpine, then added 2 mL of 1 mol/L NaOH); Acceptor sample : 100 mmol/L H3PO4, stirring rate: 600 rpm and extraction time: 60 min.
Effect of Stirring Rate
Suitable stirring of the sample solution enhances extraction and reduces the time needed to reach the thermodynamic equilibrium. The effects of the stirring rate on the enrichment factor at stirring rates of 300 - 700 rpm for the two analytes was evaluated. Fig. 3 showed that the optimum stirring rate was 600 rpm. If the stirring rate is too fast, it can deteriorate the stability of the extraction droplets, increase the solubility of the organic solvent in the donor phase and reduce the extraction efficiency.
Fig. 3.Effect of the donor solution pH on extraction efficiency.
Effect of Extraction Time
In the three-phase HF-LPME, obtaining a balance between the donor phase, organic phase and acceptor phase is a time dependent process. The effects of the extraction time on the extraction efficiency were studied from 20 to 90 min. The results in Fig. 4 suggest that the enrichment factor of two compounds increased with increasing the extraction time, but decreased when the extraction time exceeded 60 min. Therefore, 60 min was selected as the optimum extraction time.
Fig. 4.Effect of stirring rate on extraction efficiency.
Effect of Ionic Strength
The addition of salt improves the ionic strength of the donor phase and reduces the affinity of the organic compounds in the aqueous phase, which would improve the extraction efficiency of organic analytes in many conventional extraction techniques. NaCl is commonly added to analytical samples.
In this study, the ionic strength of the sample solution was optimized by spiking the donor phase with a series of NaCl concentrations ranging from 0 to 0.20 g/mL. The results showed that NaCl had almost no salting-out effect on the extraction efficiency. Therefore, this HPME system was conducted without the addition of salt.
Linearity, Reproducibility and Limits of Detection
A calibration curve of spiked urine samples was prepared by adding different volume stock solution to a 4 mL, followed by the addition of 2 mL 1mol/L NaOH and finally human urine to a total volume of 4.0 mL. The samples were then extracted using the HF-LPME procedure established above. Each extract was directly analyzed by HPLC. Fig. 5 shows the chromatograms of the blank human urine and spiked human urine extracted by HF-LPME. The linear ranges, regression equations and detection limits of matrine and sophocarpine are demonstrated in Table 2. Here Y and X represents the peak area of the analytes and the concentration of the analytes in the urine sample (μg/mL), respectively. The detection limits (S/N = 3:1) for matrine and sophocarpine were 0.025 and 0.042 μg/mL, respectively. Compared with SPE,23 HF-LPME had lower detection limits and higher sensitivity. The proposed HF-HPME method provided very high enrichment factors (Table 3): 93-fold and 123-fold for matrine and sophocarpine, respectively, meaning that trace concentrations of matrine and sophocarpine which can not be detected by conventional extraction methods could be detected sufficiently after HF-LPME concentration.
Fig. 5.Effect of extraction time on extraction efficiency.
Table 2.The regression equations, linear ranges, correlation coefficients and detection limits in human urine
Table 3.Extraction enrichment and recoveries of matrine and sophocarpine in human urine
CONCLUSIONS
The developed HF-LPME offers a simple and sensitive approach for the determination of matrine alkaloids in a biological matrix, and can lead to a high sample pre-concentration as well as an efficient sample cleanup effect. The LPME-sweeping method was applied successfully to the analysis of matrine and sophocarpine in real urine samples with high enrichment factors 93-fold and 123-fold, respectively. The results showed that HF-LPME is a promising combination for the analysis of basic drugs present at low levels in biological samples.
참고문헌
- Chen, S. Trad. Pat. Med. 2003, 25, 75.
- Ouyang, Y.; Liu, C.; Zhu, J. Chin. Pharmacol. Bull. 1997, 13, 96.
- Wong, S. K.; Tusi, S. K.; Kwan, S. Y. J. Pharm. Biomed. Anal. 2002, 30, 161. https://doi.org/10.1016/S0731-7085(02)00172-3
- Li, Y. M.; Min, G.; Xue, Q.; Chen, L.; Liu, W. M.; Chen, H. Biomed. Chromatogr. 2004, 18, 619. https://doi.org/10.1002/bmc.348
- Yu, Y.; Ding, P.; Chen, D. Anal. Chim. Acta. 2004, 523, 15. https://doi.org/10.1016/j.aca.2004.06.070
- Li, K.; Wang, H. Biomed. Chromatogr. 2004, 18, 178. https://doi.org/10.1002/bmc.308
- Sita, D. S. T.; Gao, G.; Lawa, F. C. P.; Li, P. C. H. J. Chromatogr. B, 2004, 808, 209. https://doi.org/10.1016/j.jchromb.2004.05.010
- Wang, Y.; Ma, Y.; Li, X.; Qin, F.; Lu, X.; Li, F. Biomed. Chromatogr. 2007, 21, 876. https://doi.org/10.1002/bmc.834
- Tsai, F. Y.; Lui, L. F.; Chang, B. J. Pharm. Biomed. Anal. 1999, 9, 1069. https://doi.org/10.1016/0731-7085(91)80046-C
- Kolmonen, M.; Leinonen, A.; Pelander, A.; Ojanperä, I. Anal. Chim. Acta. 2007, 585, 94. https://doi.org/10.1016/j.aca.2006.12.028
- Pacenti, M.; Dugheri, S.; Villanelli, F.; Bartolucci, G.; Calamai, L.; Boccalon, P.; Arcangeli, G.; Vecchione,F.; Alessi, P.; Kikic, I.; Cupelli, V. Biomed. Chromatogr. 2008, 22, 1155. https://doi.org/10.1002/bmc.1039
- Kataoka, H.; Inoue, R.; Yagi, K.; Saito, K. J. Pharm. Biomed. Anal. 2009, 49, 108. https://doi.org/10.1016/j.jpba.2008.09.044
- Bagheri, H.; Khalilian, F.; Ahangar, L. E. J. Sep. Sci. 2008, 31, 3212. https://doi.org/10.1002/jssc.200800193
- Liu, J.; Cai, X.; Li, Z.; Jiang, G. J. Chromatogr. A 2009, 1216, 2583. https://doi.org/10.1016/j.chroma.2009.01.092
- Basheer, C.; Alnedhary, A. A.; Rao, B. S. M.; Lee, H. K. Anal. Chim. Acta. 2007, 605, 147. https://doi.org/10.1016/j.aca.2007.10.006
- Tao, Y.; Liu, J. F.; Wang, T.; Jiang, G. B. J. Chromatogr. A 2009, 1216, 756. https://doi.org/10.1016/j.chroma.2008.11.094
- Shariati, S.; Yamini, Y.; Esrafili, A. J. Chromatogr. B 2009, 877, 393. https://doi.org/10.1016/j.jchromb.2008.12.042
- Zhang, Z.; Wang, D.; Zhang, L.; Du, M.; Chen, G. Analyst 2008, 133, 1187. https://doi.org/10.1039/b802679c
- Yang, C.; Guo, L.; Liu, X.; Zhang, H.; Liu, M. J. Chromatogr. A 2007, 1164, 56. https://doi.org/10.1016/j.chroma.2007.07.019
- Shah, F. U.; Barri, T.; Jönsson, J. A.; Skog, K. J. Chromatogr. B 2008, 870, 203. https://doi.org/10.1016/j.jchromb.2008.06.006
- Cui, S.; Tan, S.; Ouyang, G.; Pawliszyn, J. J Chromatogr A 2009, 1216, 2241. https://doi.org/10.1016/j.chroma.2009.01.022
- Ho, T. S.; Halvorsen, T. G.; Pedersen-Bjergaard, S.; Rasmussen, K. E. J. Chromatogr. A 2003, 998, 61. https://doi.org/10.1016/S0021-9673(03)00634-4
- Liu, X.; Li, Lei; Sun, J.; Sun, Y.; Zhang, T.; Chen, D.; He, Z. Chromatogr. 2006, 63, 483. https://doi.org/10.1365/s10337-006-0773-2
피인용 문헌
- Multivariate optimization of the hollow fibre liquid phase microextraction of muscimol in human urine samples vol.1033-1034, 2016, https://doi.org/10.1016/j.jchromb.2016.09.008